用还是不用?静脉对比剂在磁共振神经成像中效用的回顾性分析
该回顾性分析检索2015年PACS中74例磁共振神经成像检查,其中57例含增强前后图像,由3名有周围神经成像经验的骨肌放射科医生独立评估神经病变、肌肉去神经支配及对比剂效用4分Likert评分。所有读者所有病例的平均对比剂效用评分为1.65(1分=无额外信息,2分=轻度额外信息/支持解读),临床指征为截肢/残端神经瘤或肿块者评分略高(分别为2.3和2.1),创伤者较低(1.5),因疼痛、麻木和/或无力行MRN者最低(1.2)。结论认为静脉对比剂对多数MRN检查提供轻度至无额外信息。
要点
- 多数MRN检查中静脉对比剂平均效用评分为1.65,介于无额外信息与轻度额外信息之间。
- 临床指征为截肢/残端神经瘤或肿块时对比剂效用评分略高(2.3和2.1)。
- 因疼痛、麻木和/或无力行MRN者对比剂效用评分最低(1.2)。
核心结论
- 静脉对比剂对多数MRN检查提供轻度至无额外信息。
- 鉴于对比剂的侵入性及近期对重复对比剂暴露先前未识别风险的担忧,评估MRN中静脉对比剂的必要性很重要。
- 需要关于MRN中静脉对比剂使用的共识循证实践指南。
研究设计与样本
- 回顾性分析,检索本院PACS中2015年施行的MRN检查,共74例,其中57例包含增强前后图像。
- 所有检查由3名有周围神经成像经验的骨肌放射科医生独立评估神经病变存在/缺失、肌肉去神经支配存在/缺失及基于4分Likert量表的对比剂效用评分。
- 查阅病历获取人口学和临床数据。
关键影像表现/征象
- 评估内容包括神经病变存在/缺失、肌肉去神经支配存在/缺失及对比剂效用评分。
诊断标准与关键数值
- 对比剂效用采用4分Likert量表评分,评分1表示无额外信息,评分2表示轻度额外信息/支持解读。
- 所有读者所有病例的平均对比剂效用评分为1.65。
- 临床指征为截肢/残端神经瘤者平均对比剂效用评分为2.3,肿块者为2.1,创伤者为1.5。
- 因疼痛、麻木和/或无力行MRN者平均对比剂效用评分最低,为1.2。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine the utility of intravenous contrast in magnetic resonance neurography (MRN).
MATERIALS AND METHODS: A search of our PACS for MRN studies performed in 2015 yielded 74 MRN exams, 57 of which included pre- and post-contrast images. All studies were independently reviewed by 3 musculoskeletal radiologists with peripheral nerve imaging experience for presence/absence of nerve pathology, presence/absence of muscle denervation, and contrast utility score based on a 4-point Likert scale. The medical record was reviewed for demographic and clinical data.
RESULTS: The mean contrast utility score across all readers and all cases was 1.65, where a score of 1 indicated no additional information and a score of 2 indicated mild additional information/supports interpretation. The mean contrast utility score was slightly higher in cases with a clinical indication of amputation/stump neuroma or mass (2.3 and 2.1 respectively) and lower in cases with a clinical indication of trauma (1.5). The mean contrast utility score was lowest in patients undergoing MRN for pain, numbness, and/or weakness (1.2).
CONCLUSION: Intravenous contrast provides mild to no additional information for the majority of MRN exams. Given the invasive nature of contrast and recent concerns regarding previously unrecognized risks of repetitive contrast exposure, assessment of the necessity of intravenous contrast in MRN is important. Consensus evidence-based practice guidelines regarding intravenous contrast use in MRN are necessary.
引用
- Harrell AD, Johnson D, Samet J, et al. With or without? A retrospective analysis of intravenous contrast utility in magnetic resonance neurography. Skeletal Radiol. 2019. PMID: 31691835. doi:10.1007/s00256-019-03321-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。